As of 2025-06-30, the Relative Valuation of Portage Biotech Inc (PRTG) is 6.34 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.54 USD, the upside of Portage Biotech Inc based on Relative Valuation is 14.4%.
The range of the Relative Valuation is 6.34 - 6.34 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -0.1x - -0.1x | -0.1x |
| Fair Price | 6.34 - 6.34 | 6.34 |
| Upside | 14.4% - 14.4% | 14.4% |
| Date | P/E |
| 2025-06-26 | -0.09 |
| 2025-06-25 | -0.10 |
| 2025-06-24 | -0.08 |
| 2025-06-23 | -0.08 |
| 2025-06-20 | -0.09 |
| 2025-06-18 | -0.09 |
| 2025-06-17 | -0.09 |
| 2025-06-16 | -0.10 |
| 2025-06-13 | -0.09 |
| 2025-06-12 | -0.10 |
| 2025-06-11 | -0.11 |
| 2025-06-10 | -0.12 |
| 2025-06-09 | -0.12 |
| 2025-06-06 | -0.13 |
| 2025-06-05 | -0.13 |
| 2025-06-04 | -0.14 |
| 2025-06-03 | -0.12 |
| 2025-06-02 | -0.12 |
| 2025-05-30 | -0.13 |
| 2025-05-29 | -0.13 |
| 2025-05-28 | -0.13 |
| 2025-05-27 | -0.13 |
| 2025-05-23 | -0.12 |
| 2025-05-22 | -0.13 |
| 2025-05-21 | -0.13 |
| 2025-05-20 | -0.13 |
| 2025-05-19 | -0.13 |
| 2025-05-16 | -0.12 |
| 2025-05-15 | -0.12 |
| 2025-05-14 | -0.12 |
| 2025-05-13 | -0.13 |
| 2025-05-12 | -0.12 |
| 2025-05-09 | -0.13 |
| 2025-05-08 | -0.14 |
| 2025-05-07 | -0.14 |
| 2025-05-06 | -0.14 |
| 2025-05-05 | -0.15 |
| 2025-05-02 | -0.16 |
| 2025-05-01 | -0.17 |
| 2025-04-30 | -0.19 |
| 2025-04-29 | -0.17 |
| 2025-04-28 | -0.17 |
| 2025-04-25 | -0.13 |
| 2025-04-24 | -0.15 |
| 2025-04-23 | -0.14 |
| 2025-04-22 | -0.16 |
| 2025-04-21 | -0.14 |
| 2025-04-17 | -0.12 |
| 2025-04-16 | -0.11 |
| 2025-04-15 | -0.13 |